Patient engagement still has a long way to go, and hinges on patient access. According to the 2024 Experian State of Patient Access survey, just 28% of patients feel access has improved since the previous years. However, more than half (51%) feel it has remained static. Today’s patients are tech-savvy and have access to more…
Shannon Sharpe was having one of those 15-minutes-of-internet-infamy moments. Social media blew up in September after the retired Denver Broncos tight end — accidentally, he later said — broadcast some of his intimate activities online. One of his sponsors took advantage of the moment: the telehealth company Ro, which sells a variety of prescription medicines…
Letters to the Editor is a periodic feature. We welcome all comments and will publish a selection. We edit for length and clarity and require full names. A chronic-pain patient advocate, who has been featured previously in KFF Health News coverage, spoke out on the social platform X about our “Payback: Tracking the Opioid Settlement Cash” project: Oh,…
By MICHAEL MILLENSON “Money changes everything,” Cyndi Lauper famously sang about love to a pulsating rock ‘n’ roll beat. So, too, when it comes to financial incentives for surgeons, two new studies suggest, although “How much money?” and “What do I have to do?” are the keys to unlocking monetary motivation. The first study, a…
Responding to a question about rural hospital closures, Robert F. Kennedy Jr. talked about an innovation that he erroneously ascribed to the Cleveland Clinic. The post RFK Jr: Cleveland Clinic Has Developed an AI Nurse; The Clinic: Uh, Not True (Video) appeared first on MedCity News.
Through a new partnership, members of Christian Healthcare Ministries can pick one doctor on HealthTap’s platform for ongoing primary care. They can also access on-demand virtual urgent care. The post Christian Healthcare Ministries Partners with HealthTap for Virtual Primary Care appeared first on MedCity News.
That is the title of a paper recently published in AJMC with co-authors Suhail Thahir, Alexa Klimchak, Ivana Audhya, Lauren Sedita, and John A. Romley. The abstract is below. Objectives: To quantify the magnitude of altruism value as applied to a hypothetical new treatment for a rare, severe pediatric disease: Duchenne muscular dystrophy (DMD). Study Design: Prospective…
Novo Nordisk’s type 2 diabetes drug Ozempic has expanded its label to include chronic kidney disease. The new FDA approval comes as makers of GLP-1 drugs work to expand the uses of these products. The post New FDA Approval Adds Chronic Kidney Disease to Ozempic’s Label appeared first on MedCity News.
The Trump administration withdrew the order a day after a federal judge temporarily blocked it